Global Point-of-Care Diagnostics Market Expected to Reach USD 102.4 Billion by 2033 - IMARC Group

Global Point-of-Care Diagnostics Market Statistics, Outlook and Regional Analysis 2025-2033

The global point-of-care diagnostics market size was valued at USD 53.1 Billion in 2024, and it is expected to reach USD 102.4 Billion by 2033, exhibiting a growth rate (CAGR) of 7.6% from 2025 to 2033.

The point of care diagnostics market is mainly driven by the growing incidence of cardiovascular diseases (CVDs) and infectious diseases which necessitates accurate and timely diagnostic solutions. According to a report published by the World Health Organization (WHO) in 2024, in European region 10,000 lives are affected by the cardiovascular diseases every day, resulting in 42.5 % of deaths annually in the region. Various technological advancements have led to the development of user friendly and portable diagnostic devices, which makes POCT more accessible in various health care settings. In line with this, the growing demand for cost effective health care solutions also facilitates the adoption of POCT because it can reduce hospital stay and overall healthcare costs. In emerging economies, the rapidly growing healthcare infrastructure further propels the market demand by broadening the reach of diagnostic services. Regulatory support and favorable government initiatives further enhances the adoption of POCT technologies. These factors are contributing positively to the market growth further across the world.

The integration of digital health technologies such as mobile applications and cloud-based platforms which facilitate real-time data sharing and remote patient monitoring is also contributing positively to the market growth. Additionally, there is a growing emphasis on developing multiplexed assays that can simultaneously detect multiple biomarkers thereby increasing diagnostic efficiency. In line with this, in April 2024, Roche Diagnostics India launched a point-of-care NT-proBNP test for diabetes patients with the risk of heart failures. This innovation aims for faster diagnosis and early intervention. The shift towards portable and user-friendly devices is also notable as it allows for greater flexibility in deployment from home-based testing to use in emergency medical services. Furthermore, regulatory support and increasing investments in research and development (R&D) are fostering innovation driving the continuous evolution of the POC diagnostics landscape.

Global Point-of-Care Diagnostics Market Statistics, By Region

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others), Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others), Latin America (Brazil, Mexico, Others), and the Middle East and Africa. According to the report, North America accounted for the largest market share on account of advanced healthcare infrastructure and high adoption rates.

North America Point-of-Care Diagnostics Market Trends:

In North America, the market is driven by the technological advancements in digital integration and connectivity, which enhances the functionality and accessibility of POCT devices. With the growing focus on home based and remote testing solutions the demand for convenient healthcare options is also on the rise. The expansion of personalized medicine is prompting the development of more precise diagnostic tools is specifically tailored to individual patient needs. For example, in October 2024, BARDA and Lumous Diagnostics announced their partnership to launch FebriDx point of care test mainly aimed at improving antibiotic stewardship. This partnership intends to support the clinical study and seek CLIA-waiver approval enabling rapid testing for bacterial infections in various healthcare settings. Regulatory support and favorable government investment policies are also facilitating the greater adoption of POCT technologies across the region. The collaborations between technology firms and healthcare providers are also fostering innovation which in turn creates a positive outlook for market growth.

Asia-Pacific Point-of-Care Diagnostics Market Trends:

In Asia Pacific region the key market trends include the growing adoption of advanced technology mainly driven by the rising investment in healthcare and growing demand for early disease detection. Asia Pacific region is witnessing significant growth in telemedicine integration and mobile health solutions which enhances accessibility in remote areas. The growing focus on affordable and user-friendly devices alongside supportive government initiatives and growing healthcare infrastructure also propels the market expansion in countries like China, India, and Japan.

Europe Point-of-Care Diagnostics Market Trends:

In European region the key market trends include the integration of telemedicine and digital health which enhances remote testing and data management. The widespread adoption of portable and rapid diagnostic devices generally driven by the growing demand for immediate results is also creating a positive outlook for the market growth. Rising investments in personalized medicine, supportive government frameworks and expanding home based diagnostics are shaping the market landscape. The rising incidence of chronic diseases is also significant factor in the regions market growth.

Latin America Point-of-Care Diagnostics Market Trends:

The point of care diagnostics market in Latin America is mainly driven by the growing adoption of mobile health solutions and advanced diagnostic technologies. There is a growing demand for rapid and accessible testing mainly for chronic and infectious diseases. Rising investment in healthcare infrastructure and favorable government initiatives are further propelling the market growth. The growth of telemedicine and rising awareness of early disease detection are also contributing positively to the market growth across the region.

Middle East and Africa Point-of-Care Diagnostics Market Trends:

Key market trends in Middle East and Africa includes the rising adoption of advanced diagnostic technologies and portable testing devices in order to enhance the accessibility and availability. Rising investments by government in improving healthcare infrastructure along with the initiatives to improve the healthcare services in rural areas is also propelling the market growth. The rising incidence of chronic disease like cardiovascular diseases (CVDs) drives the demand for rapid and on-site diagnostics. The growing focus on integration of digital health solutions along with the pressing need on early disease detection also contributes positively to the market growth.

Top Companies Leading in the Point-of-Care Diagnostics Industry

Some of the leading Point-of-Care Diagnostics market companies include Abbott Laboratories, Beckman Coulter, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, Instrumentation Laboratory, Johnson & Johnson, Nova Biomedical Corporation, Pts Diagnostics, Qiagen, Siemens, Trinity Biotech, among many others. In March 2024, Nova Biomedical launched its New Generation StatStrip Glucose Hospital Meter which received FDA 510(k) clearance. This advanced meter features enhanced cyber security along with a Linux operating system, wireless charging, RFID data entry and a rugged design. Maintaining accuracy for critically ill patients the meter is compatible with existing StatStrip test strips ensuring reliable glucose testing in hospital settings.

Global Point-of-Care Diagnostics Market Segmentation Coverage

• On the basis of the product type, the market has been categorized into blood-glucose monitoring kit, cardio-metabolic monitoring kit, pregnancy and fertility testing kit, infectious disease testing kit, cholesterol test strip, hematology testing kit and others, wherein blood-glucose monitoring kit represent the leading segment. The blood glucose monitoring kit leads the point-of-care diagnostics market driven by the growing prevalence of diabetes and increasing awareness about its management. These kits offer convenience, rapid results and user-friendly interfaces making them essential for routine glucose monitoring. Technological advancements and rising adoption in home care further bolster their dominance in the market.
• Based on the platform, the market is classified into lateral flow assays, dipsticks, microfluidics, molecular diagnostics and immunoassays amongst which lateral flow assays dominates the market. Lateral flow assays dominate the point-of-care diagnostics market due to their simplicity, affordability and rapid result delivery. Widely used for infectious disease detection and pregnancy tests their versatility and minimal equipment requirements make them ideal for various healthcare settings. Continuous innovation and widespread application further reinforce their leading position in the market.
• On the basis of the prescription mode, the market has been divided into prescription-based testing and OTC testing. Among these, prescription-based testing accounts for the majority of the market share. Prescription based testing holds the largest share in the point-of-care diagnostics market driven by its reliability and professional oversight in diagnosis. These tests are preferred for complex conditions requiring accurate results under medical supervision. Their widespread use in hospitals and clinics ensures precise treatment decisions securing their dominance in the market.
• Based on the end-user, the market is segregated into professional diagnostic centers, home care, research laboratories, and others. Among these, professional diagnostic centers accounts for the majority of the market share. Professional diagnostic centers dominate the point-of-care diagnostics market due to their advanced infrastructure and ability to handle high testing volumes. These centers provide accurate and reliable results under expert supervision catering to diverse diagnostic needs. Their integration of cutting-edge technology and comprehensive services solidifies their position as the leading end user segment.